Stuart Therapeutics is a biotechnology company that offers PolyCol, a therapeutic platform for ophthalmic indications.

Biotechnology

Stuart Therapeutics

Stuart Therapeutics' headquarters in Stuart, FL, United States

Eric Schlumpf

Miles Flamenbaum

Shawn Delorey

Brian J. Del Buono

David Calkins

Diane Black

Walter Flamenbaum

Vance Thompson

Ronald T. Raines

Jay Pepose

Felipe A. Medeiros

Peter K. Kaiser

Jodi Luchs

The Scientific Team at Stuart Therapeutics focuses on research and development, leveraging the PolyCol therapeutic platform to develop innovative treatments for ophthalmic conditions. Their primary responsibilities include conducting scientific research, designing clinical trials, and advancing the product pipeline for eye-related therapeutics.

Scientific Team

This department oversees the strategic direction and governance of the organization's board members.

Board Governance

This department oversees the strategy and execution of programs, focusing on innovation and research initiatives.

Program Development

The Leadership Team at Stuart Therapeutics drives the strategic direction and vision of the company, overseeing research, clinical development, and program management for the PolyCol platform. Comprising experts in science, medicine, and business, the team collaborates to ensure the effective advancement of innovative ophthalmic therapies, aligning operational goals with regulatory compliance and market needs.

Stuart Therapeutics

Org chart

Board & advisors

Teams

Scientific Team

Board Governance

Program Development

Leadership Team

Offices

Stuart Therapeutics

Org chart

Board & advisors

Teams

Scientific Team

Board Governance

Program Development

Leadership Team

Offices

Related companies